133 related articles for article (PubMed ID: 9657014)
21. Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.
Kontos M; Allen DS; Agbaje OF; Hamed H; Fentiman IS
Eur J Surg Oncol; 2011 Dec; 37(12):1051-8. PubMed ID: 21843919
[TBL] [Abstract][Full Text] [Related]
22. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy for postmastectomy local-regional recurrent breast cancer.
Deutsch M
Am J Clin Oncol; 2000 Oct; 23(5):494-8. PubMed ID: 11039511
[TBL] [Abstract][Full Text] [Related]
24. [A Case of Breast Cancer with Local Recurrence in the Reconstructed Breast Tissue].
Tsujio G; Kashiwagi S; Hatano T; Asano Y; Goto W; Takada K; Noda S; Takashima T; Onoda N; Motomura H; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1056-1058. PubMed ID: 29394532
[TBL] [Abstract][Full Text] [Related]
25. Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects.
Dörr W; Bertmann S; Herrmann T
Strahlenther Onkol; 2005 Sep; 181(9):567-73. PubMed ID: 16170483
[TBL] [Abstract][Full Text] [Related]
26. Local recurrence after mastectomy in patients with T3pN0 breast carcinoma treated without postoperative radiation therapy.
Mignano JE; Gage I; Piantadosi S; Ye X; Henderson G; Dooley WC
Am J Clin Oncol; 2007 Oct; 30(5):466-72. PubMed ID: 17921705
[TBL] [Abstract][Full Text] [Related]
27. Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifen.
Ijichi N; Shigekawa T; Ikeda K; Miyazaki T; Horie-Inoue K; Shimizu C; Saji S; Aogi K; Tsuda H; Osaki A; Saeki T; Inoue S
Clin Breast Cancer; 2013 Dec; 13(6):465-70. PubMed ID: 24119785
[TBL] [Abstract][Full Text] [Related]
28. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.
Haffty BG; Hauser A; Choi DH; Parisot N; Rimm D; King B; Carter D
Cancer; 2004 Jan; 100(2):252-63. PubMed ID: 14716758
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.
Blamey RW; Bates T; Chetty U; Duffy SW; Ellis IO; George D; Mallon E; Mitchell MJ; Monypenny I; Morgan DA; Macmillan RD; Patnick J; Pinder SE
Eur J Cancer; 2013 Jul; 49(10):2294-302. PubMed ID: 23523089
[TBL] [Abstract][Full Text] [Related]
30. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
Novoa Vargas A; Font López KC; Amador DD
Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
[TBL] [Abstract][Full Text] [Related]
31. Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer.
Ferretti G; Mandalà M; Bria E; Carlini P; Papaldo P; Fabi A; Felici A; Cognetti F
Breast Cancer Res Treat; 2005 Apr; 90(3):319. PubMed ID: 15830147
[No Abstract] [Full Text] [Related]
32. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
33. Breast conserving treatment for ductal carcinoma in situ in the elderly: can radiation therapy be avoided? Our experience.
Falco G; Rocco N; Procaccini E; Sommella MG; Bordoni D; Cenini E; Castagnetti F; Sabatino V; Compagna R; Della Corte GA; Accurso A; Amato B; Ferrari G
Int J Surg; 2014; 12 Suppl 2():S47-S49. PubMed ID: 25167849
[TBL] [Abstract][Full Text] [Related]
34. Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence.
Winzer KJ; Sauerbrei W; Braun M; Liersch T; Dunst J; Guski H; Schumacher M;
Eur J Cancer; 2010 Jan; 46(1):95-101. PubMed ID: 19879131
[TBL] [Abstract][Full Text] [Related]
35. [Correlation of risk factors with the efficacy of applied therapies by breast conserving procedure in breast cancer].
Schwegler N; Puric E
Praxis (Bern 1994); 2003 Apr; 92(14):639-48. PubMed ID: 12723313
[TBL] [Abstract][Full Text] [Related]
36. DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences.
Harms W; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Krug D; Piroth MD; Sautter-Bihl ML; Sedlmayer F; Souchon R; Wenz F; Sauer R;
Strahlenther Onkol; 2016 Apr; 192(4):199-208. PubMed ID: 26931319
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes.
Cooke AL; Perera F; Fisher B; Opeitum A; Yu N
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):777-81. PubMed ID: 7860388
[TBL] [Abstract][Full Text] [Related]
39. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
[TBL] [Abstract][Full Text] [Related]
40. Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation.
Wazer DE; Jabro G; Ruthazer R; Schmid C; Safaii H; Schmidt-Ullrich RK
Radiat Oncol Investig; 1999; 7(2):111-7. PubMed ID: 10333252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
